Featured Research Search Results
Testing a KRAS Vaccine With Immunotherapy for Advanced Pancreatic and Colorectal Cancer
Clinicaltrials.gov identifier:
NCT06411691
Treatment
Phase 1b treatment study enrolling adults with advanced pancreatic or colorectal cancer that has a KRAS mutation and has been previously treated with chemotherapy
Testing COM701 Maintenance Treatment to Delay Cancer Growth After Platinum Chemotherapy for Ovarian Cancer That Has Come Back
Clinicaltrials.gov identifier:
NCT06888921
Treatment
Study for women with relapsed platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer who responded to their most recent platinum chemotherapy
Treating Advanced MSI-High or dMMR Cancers Using the Targeted Therapy MOMA-341 Given Alone or In Combination with Standard Therapies
Clinicaltrials.gov identifier:
NCT06974110
Treatment
Treatment study for people with advanced or metastatic cancers
Study of a New Oral Medication, Daraxonrasib After Surgery to Help Prevent Pancreatic Cancer from Returning
Clinicaltrials.gov identifier:
NCT07252232
Treatment
Phase 3 treatment trial for pancreatic cancer that was removed by surgery
Treating Advanced Cancers with DNA-Repair Mutations Using MOMA-313 Alone or In Combination with the PARP Inhibitor Olaparib
Clinicaltrials.gov identifier:
NCT06545942
Treatment
Treatment study for people with advanced or metastatic cancers
Treating Advanced Endometrial Cancer with Targeted Therapies (ComboMATCH)
Clinicaltrials.gov identifier:
NCT05554328
Treatment
Phase 2 treatment study for recurrent endometrial cancer
NePtune: Using PARP Inhibitors Before Surgery in Localized Prostate Cancer
Clinicaltrials.gov identifier:
NCT05498272
Treatment
Treatment study for people with intermediate- or high-risk prostate cancer with certain tumor mutations
Comparing an Investigational Targeted Drug AZD5335 to Standard Treatments in People With Platinum‑Resistant Ovarian Cancer (TREVI‑OC‑01)
Clinicaltrials.gov identifier:
NCT07218809
Treatment
Phase 3 treatment study for platinum-resistant ovarian cancer
Using a Blood Test to Detect Early Cancer Recurrence After Treatment (ORACLE)
Clinicaltrials.gov identifier:
NCT05059444
Treatment
Post-treatment study to monitor for recurrence
Treating Advanced or Metastatic Breast Cancer with a Type of Immunotherapy Called CAR-T
Clinicaltrials.gov identifier:
NCT06878248
Treatment
Phase 1 treatment study for people with advanced solid tumors
Comparing an Experimental Drug Puxi-Sam with Standard Chemotherapy for Metastatic Endometrial Cancer (Bluestar‑Endometrial01)
Clinicaltrials.gov identifier:
NCT07044336
Treatment
Phase 3 treatment study for metastatic endometrial cancer
Testing a Combination of Immunotherapy and a Vaccine in People With Advanced Pancreatic or Lung Cancer
Clinicaltrials.gov identifier:
NCT06015724
Treatment
Phase 2 treatment study for advanced pancreatic and lung cancer
Treating Recurrent dMMR or MSI-High Endometrial Cancer with the Immunotherapy Drug, Nivolumab with or without the Immunotherapy Drug, Ipilimumab
Clinicaltrials.gov identifier:
NCT05112601
Treatment
Phase 2 treatment study for recurrent endometrial cancer with dMMR or MSI-High biomarker
Treating Advanced Breast or Other Solid Cancers Using a Combination of a New Targeted Therapy, ZEN003694, With The Targeted Therapy Abemaciclib (Verzenio)
Clinicaltrials.gov identifier:
NCT05372640
Treatment
Phase 1 treatment study for advanced breast cancer and other solid tumors
Study of a New Targeted Therapy Given Alone or in Combination with an Immunotherapy for Metastatic, Triple-Negative Breast Cancer
Clinicaltrials.gov identifier:
NCT06841354
Treatment
Phase 3 treatment study for people with metastatic, triple-negative breast cancer
Study of a New Investigational Inhibitor to Treat People with Advanced Solid Tumors
Clinicaltrials.gov identifier:
NCT05932862
Treatment
Treatment study for people with advanced solid tumors
Using a PARP Inhibitor and Oral Chemotherapy to Treat Advanced Solid Tumors with a Mutation in BRCA1, BRCA2, PALB2, ATM or CHEK2
Clinicaltrials.gov identifier:
NCT06177171
Treatment
Phase 1 treatment study for metastatic solid tumors
Post-surgery Immunotherapy (Toripalimab) for MMR-D / MSI-H Stage IIB-III Colon Cancer
Clinicaltrials.gov identifier:
NCT07140679
Treatment
Study for people who have had surgery to remove the Stage IIB-III MMR-D / MSI-H colon cancer
Sponsored By
